1. Home
  2. ELLO vs GBIO Comparison

ELLO vs GBIO Comparison

Compare ELLO & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELLO
  • GBIO
  • Stock Information
  • Founded
  • ELLO 1987
  • GBIO 2016
  • Country
  • ELLO Israel
  • GBIO United States
  • Employees
  • ELLO N/A
  • GBIO N/A
  • Industry
  • ELLO Electric Utilities: Central
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELLO Utilities
  • GBIO Health Care
  • Exchange
  • ELLO Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • ELLO 181.0M
  • GBIO 165.5M
  • IPO Year
  • ELLO 1995
  • GBIO 2020
  • Fundamental
  • Price
  • ELLO $14.72
  • GBIO $1.43
  • Analyst Decision
  • ELLO
  • GBIO Strong Buy
  • Analyst Count
  • ELLO 0
  • GBIO 2
  • Target Price
  • ELLO N/A
  • GBIO $7.50
  • AVG Volume (30 Days)
  • ELLO 3.5K
  • GBIO 151.3K
  • Earning Date
  • ELLO 12-31-2024
  • GBIO 11-06-2024
  • Dividend Yield
  • ELLO N/A
  • GBIO N/A
  • EPS Growth
  • ELLO N/A
  • GBIO N/A
  • EPS
  • ELLO N/A
  • GBIO N/A
  • Revenue
  • ELLO $46,384,871.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • ELLO N/A
  • GBIO $188.06
  • Revenue Next Year
  • ELLO N/A
  • GBIO N/A
  • P/E Ratio
  • ELLO N/A
  • GBIO N/A
  • Revenue Growth
  • ELLO N/A
  • GBIO 514.08
  • 52 Week Low
  • ELLO $11.08
  • GBIO $1.10
  • 52 Week High
  • ELLO $20.26
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • ELLO 65.24
  • GBIO 25.39
  • Support Level
  • ELLO $13.19
  • GBIO $2.14
  • Resistance Level
  • ELLO $14.58
  • GBIO $2.57
  • Average True Range (ATR)
  • ELLO 0.51
  • GBIO 0.21
  • MACD
  • ELLO 0.04
  • GBIO -0.08
  • Stochastic Oscillator
  • ELLO 91.28
  • GBIO 1.72

About ELLO Ellomay Capital Ltd (Israel)

Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: